4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Joshua Muli Mutiso, John Chege Macharia, Maria Ndunge Kiio, James Maina Ichagichu, Hitler Rikoi, Michael Muita Gicheru. Development of Leishmania vaccines: predicting the future from past and present experience[J]. The Journal of Biomedical Research, 2013, 27(2): 85-102. DOI: 10.7555/JBR.27.20120064
Citation: Joshua Muli Mutiso, John Chege Macharia, Maria Ndunge Kiio, James Maina Ichagichu, Hitler Rikoi, Michael Muita Gicheru. Development of Leishmania vaccines: predicting the future from past and present experience[J]. The Journal of Biomedical Research, 2013, 27(2): 85-102. DOI: 10.7555/JBR.27.20120064

Development of Leishmania vaccines: predicting the future from past and present experience

More Information
  • Received Date: June 16, 2012
  • Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement and fatal systemic infection. Resistance to infection is associated with a T-helper-1 immune response that activates macrophages to kill the intracellular parasite in a nitric oxide-dependent manner. Conversely, disease progression is generally associated with a T-helper-2 response that activates humoral immunity. Current control is based on chemothera-peutic treatments which are expensive, toxic and associated with high relapse and resistance rates. Vaccination remains the best hope for control of all forms of the disease, and the development of a safe, effective and afford-able antileishmanial vaccine is a critical global public-health priority. Extensive evidence from studies in animal models indicates that solid protection can be achieved by immunization with defined subunit vaccines or live-at-tenuated strains of Leishmania. However, to date, no vaccine is available despite substantial efforts by many labo-ratories. Major impediments in Leishmania vaccine development include: lack of adequate funding from national and international agencies, problems related to the translation of data from animal models to human disease, and the transition from the laboratory to the field. Furthermore, a thorough understanding of protective immune re-sponses and generation and maintenance of the immunological memory, an important but least-studied aspect of antiparasitic vaccine development, during Leishmania infection is needed. This review focuses on the progress of the search for an effective vaccine against human and canine leishmaniasis.
  • Related Articles

    [1]Mengfan Guo, Jingyuan Liu, Yujuan Zhang, Jingjing Gu, Junyi Xin, Mulong Du, Haiyan Chu, Meilin Wang, Hanting Liu, Zhengdong Zhang. Genetic variants in C1GALT1 are associated with gastric cancer risk by influencing immune infiltration[J]. The Journal of Biomedical Research, 2024, 38(4): 348-357. DOI: 10.7555/JBR.37.20230161
    [2]Sumeng Wang, Silu Chen, Huiqin Li, Shuai Ben, Tingyu Zhao, Rui Zheng, Meilin Wang, Dongying Gu, Lingxiang Liu. Causal genetic regulation of DNA replication on immune microenvironment in colorectal tumorigenesis: Evidenced by an integrated approach of trans-omics and GWAS[J]. The Journal of Biomedical Research, 2024, 38(1): 37-50. DOI: 10.7555/JBR.37.20230081
    [3]Daohong Chen. Untoward immune effects of modern medication[J]. The Journal of Biomedical Research, 2024, 38(1): 17-23. DOI: 10.7555/JBR.37.20230071
    [4]Weixi Feng, Yanli Zhang, Peng Sun, Ming Xiao. Acquired immunity and Alzheimer's disease[J]. The Journal of Biomedical Research, 2023, 37(1): 15-29. DOI: 10.7555/JBR.36.20220083
    [5]Liu Zhi, Wang Jianwei, Ge Yiyue, Xu Yuyu, Guo Mengchen, Mi Kai, Xu Rui, Pei Yang, Zhang Qiankun, Luan Xiaoting, Hu Zhibin, Chi Ying, Liu Xingyin. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response[J]. The Journal of Biomedical Research, 2021, 35(3): 216-227. DOI: 10.7555/JBR.35.20200154
    [6]Yu Xinyu, Wu Yuan, Zhang Jiarong, Jirimutu, Zulipikaer Azhati, Chen Jin. Pre-evaluation of humoral immune response of Bactrian camels by the quantification of Th2 cytokines using real-time PCR[J]. The Journal of Biomedical Research, 2020, 34(5): 387-394. DOI: 10.7555/JBR.34.20190035
    [7]Park Ho-Eun, Do Kyung-Hyo, Lee Wan-Kyu. The immune-modulating effects of viable Weissella cibaria JW15 on RAW 264.7 macrophage cells[J]. The Journal of Biomedical Research, 2020, 34(1): 36-43. DOI: 10.7555/JBR.33.20190095
    [8]Huijeong Ahn, Hyuk Moo Kwon, Eunsong Lee, Pyeung-Hyeun Kim, Eui-Bae Jeung, GeunShik Lee. Role of inflammasome regulation on immune modulators[J]. The Journal of Biomedical Research, 2018, 32(6): 401-410. DOI: 10.7555/JBR.32.20170120
    [9]Arbind Kumar Choudhary, Rathinasamy Sheela Devi. Effects of aspartame on hsp70, bcl-2 and bax expression in immune organs of Wistar albino rats[J]. The Journal of Biomedical Research, 2016, 30(5): 427-435. DOI: 10.7555/JBR.30.20140097
    [10]Joshua M. Mutiso, John C. Macharia, Michael M. Gicheru. A review of adjuvants for Leishmania vaccine candidates[J]. The Journal of Biomedical Research, 2010, 24(1): 16-25.

Catalog

    Article Metrics

    Article views (11374) PDF downloads (3217) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return